| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $83.9M | -7.1% |
| Cost of Revenue | $1.3M | +7.6% |
| Gross Profit | $22.5M | -8.3% |
| R&D Expense | $2.9M | -45.9% |
| SG&A Expense | $4.9M | -19.8% |
| Operating Income | $12.6M | +16.8% |
| Pre-tax Income | $16.7M | +171.5% |
| Income Tax | $1.5M | -11.4% |
| Net Income | $14.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.7M | -71.0% |
| Short-term Investments | $18.5M | +557.7% |
| Accounts Receivable | $15.8M | -4.2% |
| Inventory | $23.4M | -5.0% |
| Current Assets | $92.6M | -7.2% |
| Total Assets | $115.6M | -11.4% |
| Current Liabilities | $57.5M | -20.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $13.3M | +444.8% |
| Capital Expenditures | $2.0M | +167.1% |
| Investing Cash Flow | -$1.9M | -274.5% |
| Financing Cash Flow | -$30.9M | -1178.3% |
| Free Cash Flow | $11.4M | +564.0% |
| +188.6% |
| EPS (Basic) | $1.03 | +185.8% |
| EPS (Diluted) | $1.03 | +185.8% |
| Total Liabilities |
| $62.3M |
| -21.9% |
| Stockholders' Equity | $60.2M | +20.2% |